Official Title
A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults, to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19
Brief Summary

The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

Detailed Description

The COVID-19 pandemic has caused major disruption to healthcare systems with significant
socioeconomic impacts. Currently, there are no specific treatments available against COVID-19
and accelerated vaccine development is urgently needed. A safe and effective vaccine for
COVID-19 prevention would have significant public health impact.

Completed
COVID-19
SARS-CoV-2

Biological: AZD1222

AZD1222 is a recombinant replication-defective chimpanzee adenovirus expressing the SARS-CoV-2-5 surface glycoprotein.

Biological: Placebo

Commercially available 0.9% (n/V) saline for injection.

Eligibility Criteria

Inclusion Criteria:

- Increased risk of SARS-CoV-2 infection

- Medically stable

Exclusion Criteria:

- confirmed or suspected immunosuppressive or immunodeficient state

- significant disease, disorder, or finding

- Prior or concomitant vaccine therapy for COVID-19

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 130 Years
Countries
Chile
Peru
United States
Locations

Research Site
Phoenix, Arizona, United States

Research Site
Scottsdale, Arizona, United States

Research Site
Little Rock, Arkansas, United States

Research Site
Berkeley, California, United States

Research Site
El Centro, California, United States

Research Site
Los Angeles, California, United States

Research Site
Los Angeles, California, United States

Research Site
San Diego, California, United States

Research Site
San Diego, California, United States

Research Site
San Francisco, California, United States

Research Site
San Francisco, California, United States

Research Site
Torrance, California, United States

Research Site
Denver, Colorado, United States

Research Site
Danbury, Connecticut, United States

Research Site
Coral Gables, Florida, United States

Research Site
Lake Worth, Florida, United States

Research Site
Miami Lakes, Florida, United States

Research Site
Orlando, Florida, United States

Research Site
Honolulu, Hawaii, United States

Research Site
Meridian, Idaho, United States

Research Site
Chicago, Illinois, United States

Research Site
Indianapolis, Indiana, United States

Research Site
Ankeny, Iowa, United States

Research Site
Fairway, Kansas, United States

Research Site
Kansas City, Kansas, United States

Research Site
Wichita, Kansas, United States

Research Site
Wichita, Kansas, United States

Research Site
Lexington, Kentucky, United States

Research Site
Lake Charles, Louisiana, United States

Research Site
Monroe, Louisiana, United States

Research Site
Baltimore, Maryland, United States

Research Site
Baltimore, Maryland, United States

Research Site
Bethesda, Maryland, United States

Research Site
Boston, Massachusetts, United States

Research Site
Boston, Massachusetts, United States

Research Site
Ann Arbor, Michigan, United States

Research Site
Royal Oak, Michigan, United States

Research Site
Minneapolis, Minnesota, United States

Research Site
Gulfport, Mississippi, United States

Research Site
Butte, Montana, United States

Research Site
Portsmouth, New Hampshire, United States

Research Site
Berlin, New Jersey, United States

Research Site
Albuquerque, New Mexico, United States

Research Site
Bronx, New York, United States

Research Site
Brooklyn, New York, United States

Research Site
Mineola, New York, United States

Research Site
New York, New York, United States

Research Site
New York, New York, United States

Research Site
New York, New York, United States

Research Site
Rochester, New York, United States

Research Site
Rochester, New York, United States

Research Site
Valhalla, New York, United States

Research Site
Durham, North Carolina, United States

Research Site
Cincinnati, Ohio, United States

Research Site
Columbus, Ohio, United States

Research Site
Yukon, Oklahoma, United States

Research Site
Portland, Oregon, United States

Research Site
Pittsburgh, Pennsylvania, United States

Research Site
Warwick, Rhode Island, United States

Research Site
Charleston, South Carolina, United States

Research Site
North Charleston, South Carolina, United States

Research Site
Spartanburg, South Carolina, United States

Research Site
Knoxville, Tennessee, United States

Research Site
Nashville, Tennessee, United States

Research Site
Austin, Texas, United States

Research Site
Dallas, Texas, United States

Research Site
Fort Sam Houston, Texas, United States

Research Site
Houston, Texas, United States

Research Site
McAllen, Texas, United States

Research Site
San Antonio, Texas, United States

Research Site
Spring, Texas, United States

Research Site
West Jordan, Utah, United States

Research Site
Burlington, Vermont, United States

Research Site
Fort Belvoir, Virginia, United States

Research Site
Richmond, Virginia, United States

Research Site
Seattle, Washington, United States

Research Site
South Charleston, West Virginia, United States

Research Site
Madison, Wisconsin, United States

Research Site
Quillota, Chile

Research Site
Santiago, Chile

Research Site
Santiago, Chile

Research Site
Callao, Peru

Research Site
Cercado De Lima, Peru

Research Site
Lima, Peru

Iqvia Pty Ltd
NCT Number
Keywords
COVID-19 vaccine
MeSH Terms
COVID-19